CCM
BCAB icon

CAAS Capital Management’s BioAtla BCAB Stock Holding History

CAAS Capital Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,602
Closed -$215K – 693
2023
Q1 		$215K Buy
1,602
+325
+25% +$58.5K 0.01% 535
2022
Q4 		$527K Buy
+1,277
New +$530K 0.03% 394
2021
Q2 		– Sell
-1,400
Closed -$3.56M – 1040
2021
Q1 		$3.56M Hold
1,400
– – 0.04% 439
2020
Q4 		$2.38M Buy
+1,400
New +$2.34M 0.02% 462

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAAS Capital Management's BCAB Position: Q2 2023 in Review

CAAS Capital Management sold out of BioAtla (BCAB) in Q2 2023, closing a stake of 1,602 shares — an estimated $215K sold.

CAAS Capital Management first reported a position in BCAB in Q4 2020 and held it in 4 quarters. The position peaked at $3.56M in Q1 2021. 87 funds tracked by Wall St. Rank hold BCAB as of Q2 2023.

  • CAAS Capital Management reported no remaining BioAtla position as of Q2 2023 after selling out during the quarter.
  • CAAS Capital Management sold 1,602 BioAtla shares in Q2 2023, an estimated $215K.
  • CAAS Capital Management first reported a position in BioAtla in Q4 2020 and held it in 4 quarters.
  • CAAS Capital Management's BioAtla position peaked at $3.56M in Q1 2021.
  • 87 funds tracked by Wall St. Rank held BioAtla as of Q2 2023.

Based on CAAS Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.